
Sign up to save your podcasts
Or
Alphabet shares are falling today after a downgrade at UBS. The stock – and many others – have made big gains this year on hopes for the future of AI.
We’ll talk to the analyst behind the call, who says the transition to AI search will definitely have some growing pains.
Plus, we’ve got new developments in the battle over weight loss drugs, including promise for Eli Lilly and a setback for Pfizer. We’ll tell you all you need to know.
4.3
1515 ratings
Alphabet shares are falling today after a downgrade at UBS. The stock – and many others – have made big gains this year on hopes for the future of AI.
We’ll talk to the analyst behind the call, who says the transition to AI search will definitely have some growing pains.
Plus, we’ve got new developments in the battle over weight loss drugs, including promise for Eli Lilly and a setback for Pfizer. We’ll tell you all you need to know.
4,078 Listeners
1,364 Listeners
238 Listeners
3,179 Listeners
147 Listeners
327 Listeners
67 Listeners
153 Listeners
2,129 Listeners
602 Listeners
545 Listeners
20 Listeners
200 Listeners
407 Listeners
302 Listeners
115 Listeners
807 Listeners
181 Listeners
60 Listeners
156 Listeners
34 Listeners
16 Listeners
9 Listeners
276 Listeners
15 Listeners